Puma Biotechnology | PBYI - Action





Action Changement Date
Agios Pharmaceuticals USD 32.92M 886K 2025-12
Alnylam Pharmaceuticals USD 82.72M 7.34M 2025-12
Amgen USD 6.22B 121M 2025-12
Biogen USD 2.17B 41.3M 2025-12
BioMarin Pharmaceutical USD 1.3B 83.29M 2025-12
Daiichi Sankyo JPY 608.55B 93.64B 2025-09
Esperion Therapeutics USD 108.54M 5.93M 2025-09
Exelixis USD 27.4M 3.92M 2025-09
Gilead Sciences USD 1.78B 40M 2025-09
Glaxosmithkline GBP 6.12B 46M 2025-09
Incyte USD 101.06M 17.61M 2025-12
MacroGenics USD 7.91M 840K 2025-12
Moderna USD 332M 92M 2025-09
Novartis USD 6.42B 114M 2025-09
Pfizer USD 11.47B 201M 2025-09
PTC Therapeutics USD 79.65M 26.96M 2025-12
Puma Biotechnology USD 9.48M 885K 2025-09
Regeneron Pharmaceuticals USD 3.2B 53.6M 2025-12
Roche Holding CHF 7.6B 9M 2025-06
Sarepta Therapeutics USD 914.74M 162.42M 2025-12
Takeda JPY 1.41T 107.71B 2025-12
TG Therapeutics USD 125.59M 21.37M 2025-12
Ultragenyx Pharmaceutical USD 52.2M 5.7M 2025-09
Vanda Pharmaceuticals USD 1.85M 190K 2025-12
Vertex Pharmaceuticals USD 1.69B 60M 2025-12